Carlsmed, Inc. Common Stock - Asset Resilience Ratio
Carlsmed, Inc. Common Stock (CARL) has an Asset Resilience Ratio of 18.44% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Carlsmed, Inc. Common Stock (CARL) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how Carlsmed, Inc. Common Stock's Asset Resilience Ratio has changed over time. See CARL total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Carlsmed, Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Carlsmed, Inc. Common Stock.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $24.00 Million | 18.44% |
| Total Liquid Assets | $24.00 Million | 18.44% |
Asset Resilience Insights
- Good Liquidity Position: Carlsmed, Inc. Common Stock maintains a healthy 18.44% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Carlsmed, Inc. Common Stock Industry Peers by Asset Resilience Ratio
Compare Carlsmed, Inc. Common Stock's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcidion Group Ltd
AU:ALC |
Health Information Services | 32.45% |
|
DocCheck AG
XETRA:AJ91 |
Health Information Services | 6.71% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 48.49% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
|
Singular Health Group Ltd
AU:SHG |
Health Information Services | 0.15% |
Annual Asset Resilience Ratio for Carlsmed, Inc. Common Stock (2024–2025)
The table below shows the annual Asset Resilience Ratio data for Carlsmed, Inc. Common Stock.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 18.44% | $24.00 Million | $130.12 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $51.82 Million | -- |
About Carlsmed, Inc. Common Stock
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more